RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Murali Yallapu to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Murali Yallapu has written about Antiviral Agents.
Murali Yallapu
Connection Strength
0.447
Antiviral Agents
  1. Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. 2022 04; 14(5):351-371.
    View in: PubMed
    Score: 0.161
  2. Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules. 2020 Dec 13; 25(24).
    View in: PubMed
    Score: 0.148
  3. Dhasmana A, Kashyap VK, Dhasmana S, Kotnala S, Haque S, Ashraf GM, Jaggi M, Yallapu MM, Chauhan SC. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach. Curr Pharm Des. 2020; 26(41):5300-5309.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support